Correlation Between Caribou Biosciences and Abcellera Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Abcellera Biologics, you can compare the effects of market volatilities on Caribou Biosciences and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Abcellera Biologics.

Diversification Opportunities for Caribou Biosciences and Abcellera Biologics

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Caribou and Abcellera is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Abcellera Biologics go up and down completely randomly.

Pair Corralation between Caribou Biosciences and Abcellera Biologics

Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Abcellera Biologics. In addition to that, Caribou Biosciences is 1.11 times more volatile than Abcellera Biologics. It trades about -0.18 of its total potential returns per unit of risk. Abcellera Biologics is currently generating about 0.0 per unit of volatility. If you would invest  295.00  in Abcellera Biologics on October 13, 2024 and sell it today you would lose (3.00) from holding Abcellera Biologics or give up 1.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Caribou Biosciences  vs.  Abcellera Biologics

 Performance 
       Timeline  
Caribou Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Abcellera Biologics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Caribou Biosciences and Abcellera Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Caribou Biosciences and Abcellera Biologics

The main advantage of trading using opposite Caribou Biosciences and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.
The idea behind Caribou Biosciences and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance